Clinical Trial Update: Determining the Optimal Dose of Tenecteplase Before Endovascular Therapy for Ischaemic Stroke (EXTEND-IA TNK Part 2) [Phase 2]

View source ↗

Summary

Phase 2 trial updating the optimal dose of tenecteplase before endovascular therapy for ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: Neuroscience Trials Australia | Conditions: Ischemic Stroke | Phase 2 | Status: COMPLETED